Outsourcing Pharma Puts Spotlight on Power of Causality, Highlights GNS-Celgene Deal Licensing REFS

Celgene has made a second investment in a machine learning and simulation platform for applications across drug discovery, clinical development, and commercialization.
Read the full story here.